The human gut hosts trillions of beneficial microbes that play a vital role in maintaining health. However, disruptions in this complex ecosystem—known as the gut microbiome—have been linked to conditions such as obesity, asthma, and cancer. Despite growing evidence of its importance, clinicians still lack fast and practical tools to diagnose microbiome-related problems.
Study Shows Gut Bacteria Can Be Identified Through Breath
As reported by medicalxpress, researchers from Washington University School of Medicine in St. Louis and Children’s Hospital of Philadelphia have now demonstrated that disease-associated gut bacteria can be detected through exhaled breath. Their study shows that chemicals released by intestinal microbes and captured in breath samples can accurately reflect the composition of bacteria in the gut.
Importantly, the researchers found that breath samples from children with asthma could predict the presence of specific gut bacteria associated with the condition. The findings were published in Cell Metabolism.
A Path Toward Rapid, Noninvasive Diagnostics
The discovery could pave the way for a rapid, noninvasive test that allows clinicians to monitor gut health simply by analysing a patient’s breath.
“Rapid assessment of gut microbiome health could significantly enhance clinical care, especially for young children,” said Dr. Andrew L. Kau, Associate Professor at the John T. Milliken Department of Medicine at WashU Medicine and senior author of the study. “Early detection could enable timely intervention for conditions such as allergies and serious infections in preterm infants.”
How Breath Reflects Gut Microbial Activity
As gut microbes digest food components that the human body cannot process, they release chemicals called volatile organic compounds. These compounds travel through the bloodstream and are expelled in exhaled breath.
Building on this biological insight, the research team explored whether breath-based compounds could serve as indicators of the gut’s microbial makeup.
Clinical Study Confirms Breath–Microbiome Link
The team, led by Dr. Kau, first author Ariel J. Hernandez-Leyva, and co-corresponding author Dr. Audrey R. Odom John, conducted a clinical study involving children aged six to 12 years. They analysed breath and stool samples from 27 healthy participants to identify links between specific microbes and breath-derived compounds.
The researchers found that the chemical signatures in the children’s breath closely matched the compounds produced by microbes present in their stool. This confirmed that breath analysis can serve as a reliable proxy for assessing gut microbial composition.
Animal Studies Reinforce the Findings
To further validate the results, the researchers conducted parallel experiments in mice. By transplanting gut bacteria into mice that initially lacked their own microbiome, they again demonstrated that specific gut microbes could be identified through breath compounds. These findings reinforced the consistency of the breath-based detection approach across species.
Applications in Asthma and Pediatric Care
The researchers then compared breath and stool samples from healthy children with those from children diagnosed with asthma. Pediatric asthma, which affects nearly five million children in the United States, is associated with higher levels of the gut bacterium Eubacterium siraeum.
Through breath analysis alone, the team successfully predicted the abundance of E. siraeum in children with asthma. Such early detection could help clinicians identify microbiome changes that may worsen asthma symptoms.
Similarly, routine breath-based screening in premature infants could help detect early microbiome disruptions that signal an increased risk of infection.
Implications for Future Clinical Practice
The study’s findings may guide the development of practical, noninvasive breath tests for routine microbiome monitoring. WashU Medicine researchers have previously developed breath-based diagnostic tools, including a test capable of detecting COVID-19 in under a minute.
“One of the biggest challenges in applying microbiome science to patient care is the time required for data analysis,” said Hernandez-Leyva. “Breath analysis offers a fast, noninvasive way to assess the gut microbiome and has the potential to transform disease diagnosis and monitoring in clinical medicine.”
Together, these findings highlight a promising new approach to diagnosing microbiome-related diseases and advancing personalised, preventive healthcare.